Evidence map›Paper›PMID 41339440›Full record

ArticleScientific reports2025

HyperGraph-based capsule temporal memory network for efficient and explainable diabetic retinopathy detection in retinal imaging.

Mishmala Sushith, N Malligeswari, M Anlin Sahaya Infant Tinu, M Jaiganesh

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mishmala SushithDepartment of Information Technology, Adithya Institute of Technology, Kurumbapalayam, Coimbatore, 641107, Tamil Nadu, India. mishmalasushith1926@gmail.com.
N MalligeswariDepartment of Electronics and Communication Engineering, Easwari Engineering college, Ramapuram, Chennai, 600089, Tamil Nadu, India.
M Anlin Sahaya Infant TinuDepartment of Biomedical Engineering, Rohini College of Engineering and Technology, Anjugramam, 629401, Tamil Nadu, India.
M JaiganeshDepartment of Information Technology, Karpagam College of Engineering, Coimbatore, 641032, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic retinopathy (DR) is a chronic complication of diabetes in which the retinal damage may cause vision impairment or blindness if left untreated. The challenges in DR detection are mostly due to the morphological variations of retinal lesions, e.g., microaneurysms, hemorrhages, and exudates, and the imaging condition variability between different clinical environments. Current state of the art deep learning models like convolutional neural network (CNN), recurrent neural network (RNN) and transformer-based architectures are computationally expensive, not robust to noisy datasets and have limitation on interpretability, which makes them difficult to deploy in real world clinical settings. This research offers HyperGraph Capsule Temporal Network (HGCTN), a deep learning framework to address these limitations and to create an accurate, scalable, and interpretable DR detection. Combining hypergraph neural networks for strong modeling of higher order spatial relationships between retinal lesions, capsule networks for permitting hierarchical structuring of feature and memorizing distributed routing place into temporal capsular memory unit (TCMU) for maintaining both long term and short termed temporal dependencies we propose HGCTN, a model that integrates all the methodologies to efficaciously track disease progression. Meta learning techniques and noise injection strategies are used to improve adaptability of the model and thus make the model more resilient to real world image variations. On DRIVE and Diabetic Retinopathy datasets, HGCTN is validated experimentally, and the best accuracy is 99.0% (HDCTN) and 98.8% (ADTATC), while existing models like TAHDL (96.7%) and ADTATC (98.2%) are outperformed. Furthermore, the model has a recall of 100% and 99.8% on DRIVE and the Diabetic Retinopathy dataset, respectively, with a specificity of 99.7% and 99.6%, respectively, and thus has almost no false negatives and a high reliability in identifying DR cases. Hypergraph attention maps and capsule activation images are additionally relied on to validate the model's interpretability as they offer explainable predictions to a clinical audience. HGCTN has high classification accuracy, reduced computational complexity and better generalization than the existing models, which makes it a new benchmark for DR detection, solving the key deficiency of the existing models and laying the foundation for the real-world deployment of the automated ophthalmic diagnosis systems.

Indexed as

Diabetic RetinopathyImage Processing, Computer-AssistedNeural Networks, ComputerRetinaDeep LearningHumansAttention-Based disease classificationAutomated retinal screeningCapsule-Based feature extractionDeep learning in ophthalmologyDiabetic retinopathy detectionHierarchical feature representationHyperGraph neural networksMedical image analysisMeta-Learning for medical imagingTemporal capsule memory unit

Identifiers

PMID41339440
PMCPMC12775537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.